A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule

L. Serrone, M. Zeuli, T. Gamucci, M. Nardi, F. Cognetti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds